Differential Expression of Parathyroid Hormone–Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Adrenocortical tumors (ACT) are rare and heterogeneous, but their pathogenesis is unclear. The oncoprotein parathyroid hormone–related protein (PTHrP), found in many common tumors, can regulate their growth in an autocrine/paracrine fashion through the PTH-R1 receptor. Little is known about the role of PTHrP in ACT. We monitored the synthesis of PTHrP and PTH-R1 in a series of 25 ACT: 12 adrenocortical carcinomas (ACC) and 13 adrenocortical adenomas (ACA), and investigated the effects of PTHrP(1-34) on H295R cells derived from an ACC. PTH-R1 mRNA and proteins were detected by real-time PCR and Western blotting in all the ACT samples and in H295R cells. Their concentrations did not differ significantly from one ACT to another. PTHrP mRNA was assayed by quantitative real-time PCR. It was detected in 90% of ACC, and in 10% of ACA. There was a positive correlation with the prognostic factors, McFarlane stage and Weiss score. Tissue-specific PTHrP protein processing was shown by Western blotting. Immunohistochemical staining revealed numerous, dense foci of PTHrP-containing cells in ACC, but few positive cells in ACA or normal tissue. PTHrP stimulated the growth of H295R cells, whereas a specific anti-PTHrP antibody and a PTHrP-R1 antagonist both enhanced their apoptosis. PTHrP activated both adenylate cyclase/protein kinase A and the intracellular calcium/protein kinase C pathways via PTHrP-R1. The active synthesis of PTHrP is linked to poor prognosis in ACC, in which it may act as an autocrine/paracrine factor in tumor growth and malignancy. (Cancer Epidemiol Biomarkers Prev 2008;17(9):2275–85)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474 · cited 7×
“Lastly, we investigated the function of PTHrP(1-34) by measuring its effect on the proliferation, cell cycle progression, and apoptosis of H295R cells using an antagonist of PTHrP, PTHrP(7-34), and a specific antiPTHrP NH2 terminus antibody.”
BackgroundMethodSelf-citationAbiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435 · cited 7×
“Lastly, we investigated the function of PTHrP(1-34) by measuring its effect on the proliferation, cell cycle progression, and apoptosis of H295R cells using an antagonist of PTHrP, PTHrP(7-34), and a specific antiPTHrP NH2 terminus antibody.”
BackgroundMethodSelf-citationMolecular genetics of adrenocortical tumours, from familial to sporadic diseases
Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168 · cited 7×
“However, the pathophysiology of ACTs is not well documented because very few genetic alterations have been identified in these tumors (19, 20).”
BackgroundMethodSelf-citationPTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells
Mazzocchi, G., Aragona, F., Malendowicz, L. K., & Nussdorfer, G. G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e209 · Cited by 123
Cited by
ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome
Assié, G., Libé, R., Espiard, S., Rizk-Rabin, M., Guimier, A., Luscap, W., Barreau, O., Lefèvre, L., Sibony, M., Guignat, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304603 · Cited by 395
Self-citationPrimary Hyperparathyroidism With Concurrent Primary Aldosteronism
Maniero, C., Fassina, A., Guzzardo, V., Lenzini, L., Amadori, G., Pelizzo, M. R., Gomez-Sanchez, C., & Rossi, G. P. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173948 · Cited by 94
Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism
Maniero, C., Fassina, A., Seccia, T. M., Toniato, A., Iacobone, M., Plebani, M., De Caro, R., Calò, L. A., Pessina, A. C., & Rossi, G. P. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f0451 · Cited by 87
“This observation may be important because PTH enhances the aldosterone response to Ang II, stimulates in a concentration-dependent fashion the secretion of aldosterone, exerts a proliferogenic effects in adrenocortical carcinoma cell line [9].”
BackgroundResultInfluentialRossi, G. P., Ragazzo, F., Seccia, T. M., Maniero, C., Barisa, M., Calò, L. A., Frigo, A. C., Fassina, A., & Pessina, A. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195891 · Cited by 76
“The PTH-related peptide, a mediator of cancer hypercalcemia that also acts on the type 1 PTH receptor, was also reported to stimulate aldosterone(13,15) and to induce proliferation of human adrenocortical carcinoma cells.(16) Furthermore, infusion of aldosterone in rats caused an increase of”
Background
Metadata
- Authors
- Rizk-Rabin, M., Assie, G., Rene-Corail, F., Perlemoine, K., Hamzaoui, H., Tissier, F., Lieberherr, M., Bertagna, X., Bertherat, J., & Bouizar, Z.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2008-09-01
- Volume
- 17
- Issue
- 9
- Pages
- 2275-2285
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2106306327
- Cited by
- 30
- References
- 4
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Expression of Parathyroid Hormone–Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells. https://app.cochat.ai/papers/10.1158/1055-9965.epi-07-2924
- The paper
- Rizk-Rabin, M., Assie, G., Rene-Corail, F., Perlemoine, K., Hamzaoui, H., Tissier, F., Lieberherr, M., Bertagna, X., Bertherat, J., & Bouizar, Z. (2008). Differential Expression of Parathyroid Hormone–Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-07-2924
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.